期刊文献+

NSE、Cyfra21-1和CEA在小细胞肺癌与非小细胞肺癌检测中的敏感性比较 被引量:7

Comparision of sensitivity of NSE,Cyfra 21-1 and CEA in detection of lung carcinoma of SCLC and NSCLC
原文传递
导出
摘要 目的通过检测比较小细胞肺癌与非小细胞肺癌血清中癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、细胞角蛋白19片段(Cyfra21-1)的水平,探讨三个指标在小细胞肺癌(SCLC)和非小细胞肺癌(NSCLC)检测中的敏感性。方法共检测小细胞肺癌患者43例,非小细胞肺癌78例,健康对照组60例,测定各组血清CEA、NSE、Cyfra21-1水平,比较各组差异。结果非小细胞肺癌组和小细胞肺癌组CEA、NSE、Cyfra21-1浓度明显高于正常对照组(P<0.05),NSE在小细胞肺癌患者中的阳性检出率明显高于非小细胞肺癌组,且具有统计学意义(P<0.05),Cyfra21-1在非小细胞肺癌组的阳性检出率明显高于小细胞肺癌组,且具有统计学意义(P<0.05),CEA在两组间阳性检出率差异无统计学意义(P>0.05)。结论 NSE对小细胞肺癌较为敏感,Cyfra21-1对非小细胞肺癌较为敏感,NSE和Cyfra21-1在小细胞肺癌与非小细胞肺癌鉴别诊断中具有重要辅助意义。 ObjectiveTo investigate the sensitivity of CEA, NSE and Cyfra21 -1 in SCLC and NSCLC by comparison with the level of serum CEA, NSE, Cyfra21 - 1 in the two groups. Methods Serum CEA, NSE and Cyfra21 - 1 were detected in 43 paitents of SCLC and 78 patients of NSCLC and 60 patients as healthy control group, then compared the difference of three groups. Results The level of Serum CEA,NSE and Cyfra21 - 1 in SCLC and NSCLC were differently higher than the healthy control group ( P 〈 0.05 ) , the positive rate of NSE in SCLC differently higher than NSCLC, the differ- ence had statistical significance (P 〈0. 05 ), the positive rate of Cyfra21 - 1 in NSCLC differently higher than that of SCLC, the difference had statistical significance (P 〈 0. 05 ), the positive rate of CEA has no statistical significance between the two groups (P 〉 0. 05 ). Conclusions NSE is sensitive in SCLC, Cyfra21 -1 is sensitive in NSCLC, NSE and Cyfra21 - 1 have important auxiliary value in differential diagnosis of SCLC and NSCLC.
出处 《医药论坛杂志》 2012年第9期16-18,23,共4页 Journal of Medical Forum
关键词 小细胞肺癌 非小细胞肺癌 肿瘤标志物 CEA NSE Cyfra21—1 Small cell lung carcinoma Non - small cell lung carcinoma Tumor marker Carcinoembryonic antigen Neuronspecific enolase Cyfra21 - 1
  • 相关文献

参考文献9

  • 1Web site: www. cancer, gov.
  • 2John Thompson, Wolfgang Zimmermann. The Carcinoembryonic Antigen Gene Family: Structure, Expression and Evolution [ J ]. Tumor Biol, 1988,9 (2 - 3 ) :63-83.
  • 3Miedouge M, Devy A, Simon M, et al. High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1,2,10,11,14 or filaggrin in the serum of squamous cell lung carcinoma patients [ J]. Tumor Biol,2001,22 ( 1 ) : 19-26.
  • 4Paone G, Angelis G, Munno R, et al. Discriminant analysis on small cell lung cancer and non - small cell lung cancer by means of NSE and Cyfra - 21. 1 [ J ]. Eur Respir, 1995,8 ( 7 ) : 1136- 1140.
  • 5Stieber P, Hasholzner U, Bodenmueller H, et al. Cyfra 21 - 1 : Anew marker in lung cancer [ J]. Cancer, 1993,72:707-713.
  • 6洪萍.CEA、NSE、CYFRA21-1联合检测在肺癌诊断中的价值[J].淮海医药,2011,29(5):408-409. 被引量:2
  • 7吴杰,骆骥才,张钧,谢鑫友.CEA、CA125、NSE、CYFRA21-1、SCC联合应用诊断肺癌的意义[J].临床检验杂志,2011,29(7):535-537. 被引量:14
  • 8Lamerz R. NSE(Neuronen - spezifisehe Enolase) ,γ - Enolase. Thomas L( ed. ) Cli - nical Laboratory Diagnosis, TH - Books, Frankfurt, 1 st English Edition 1998 : 979 - 981,5 [ M ]. deutsche Auflage, 1998 : 1000-1003.
  • 9陆国军,于力克,张宇.血清CEA、NSE、SCC-Ag、CYFRA21-1联合检测对肺癌的诊断价值[J].临床肺科杂志,2011,16(8):1282-1283. 被引量:11

二级参考文献19

  • 1时广利,胡秀玲,岳思东,宋长兴.血清肿瘤标志物在肺癌辅助诊断中的应用[J].中华肿瘤杂志,2005,27(5):299-301. 被引量:82
  • 2梁婧,周光英,刘文波,刘海荣.原发性肺癌患者外周血肿瘤标记物联合检测的临床意义[J].实用癌症杂志,2005,20(2):154-157. 被引量:5
  • 3万锦平,黄建安,刘皓,张秋娣.血清SCC-Ag、CYFRA21-1、NSE、CEA联合检测对肺癌的诊断价值[J].临床肺科杂志,2007,12(2):111-112. 被引量:54
  • 4曾显声,周燕斌.肺癌血清肿瘤标志物的研究现状[J].国际内科学杂志,2007,34(2):73-76. 被引量:51
  • 5Plebani M,Basso D,Navaglia F,et al.Clinial evaluation of seven tumour markers in ling cancer diagnosis:can any combination improve the results[J].Br J cancer,1995,72(1):170-173.
  • 6Holdenrieder S, von Pawel J, Dankelmann E, et al. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer[ J], Clin Cancer Res ,2008, 14(23) :7813 -7821.
  • 7Tomita M, Shimizu T, Ayabe T, et al. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21 - 1 in nonsmall cell lung cancer [ J ]. Antieancer Res,2010,30 ( 7 ) : 3099 -4102.
  • 8Molina R. Filella X, Auge JM, et al. Tumor markers ( CEA, CA125, CYFRA21-1 ,SCC and NSE)in patients with non-small cell lung canc- er as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors [ J ]. Tumour Biol, 2003,24(2) :209-218.
  • 9Bekci TT, Senol T, Maden E. The efficacy of serum carcinoembryonic antigen( CEA ), cancer antigen 125 ( CA125 ), carbohydrate antigen 19 -9 ( CA19 -9 ), carbohydrate antigen 15-3 ( CA15-3 ), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determi- ning the malignancy of solitary pulmonary nodules [ J]. J lnt Med Res, 2009,37 (2) :438-445.
  • 10Homma S, Satoh H, Kagohashi K,et al. Production of CA125 by hu- man lung cancer cell lines[ J]. Clin Exp Med ,2004,4(3) :139-141.

共引文献24

同被引文献71

  • 1时广利,时广利,尹颜军,时广利,刘继芬,荣长利,时广利,梁子坤.肺癌患者血清中新型肿瘤标志物CK18-3A9检测的临床意义[J].中华临床医师杂志(电子版),2012,6(19):5831-5833. 被引量:6
  • 2孙雪飞,陈景寒,孟龙,杜贾军,杨奎忠.当归补血汤Ⅰ号在非小细胞肺癌术前BAI化疗中的作用[J].山东大学学报(医学版),2006,44(3):280-282. 被引量:3
  • 3SpodenGA,Mazurek S,Morandell D,et al. Isotype specific inhibi- tots of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation[J]. Int J Cancer, 2008,123(2):312-321.
  • 4Ueno T,Toi M, Linder S. Detection of epithelial cell death in the body by eytokeratin 18 measurement[J]. Biomed Pharmacother, 2005,59 Suppl 2:$359-362.
  • 5Hardt PD,Ewald N. Tumor M2 pyruvate kinase:a tumor marker and its clinical application in gastrointestinal malignancy[J]. Ex- pert Rev Mol Diagn,2008,8(5):579-585.
  • 6Brown T,Pilkington G,Bagust A,et al.Corrigendum:Clinical effectiveness and cost-effectiveness of firstline chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer:a systematic review and economic evaluation[J].Health Technol Assess,2015,17:281-282.
  • 7Jiang AG,Chen HL,Lu HY.The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer[J].BMC Cancer,2015,15:386.
  • 8Szturmowicz M,Rudzinski P,Kacprzak A,et al.Prognostic value of serum C-reactive protein(CRP)and cytokeratin 19fragments(Cyfra 21-1)but not carcinoembryonic antigen(CEA)in surgically treated patients with non-small cell lung cancer[J].Pneumonol Alergol Pol,2014,82:422-429.
  • 9Cedres S,Nunez I,Longo M,et al.Serum tumor markers CEA,CYFRA21-1,and CA-125are associated with worse prognosis in advanced non-small-cell lung cancer(NSCLC)[J].Clin Lung Cancer,2011,12:172-179.
  • 10Huang C,Ma R,Xu Y,et al.Wnt2promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway[J].Am J Cancer Res,2015,5:1032-1046.

引证文献7

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部